Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Return on Equity (2019 - 2025)

Revolution Medicines (RVMD) has 7 years of Return on Equity data on record, last reported at 0.7% in Q4 2025.

  • For Q4 2025, Return on Equity fell 39.0% year-over-year to 0.7%; the TTM value through Dec 2025 reached 0.7%, down 39.0%, while the annual FY2025 figure was 0.58%, 29.0% down from the prior year.
  • Return on Equity reached 0.7% in Q4 2025 per RVMD's latest filing, down from 0.56% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.2% in Q2 2021 and bottomed at 0.7% in Q4 2025.
  • Average Return on Equity over 5 years is 0.36%, with a median of 0.32% recorded in 2023.
  • Peak YoY movement for Return on Equity: soared 32bps in 2021, then tumbled -39bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.3% in 2021, then decreased by -21bps to 0.36% in 2022, then increased by 10bps to 0.33% in 2023, then rose by 5bps to 0.31% in 2024, then tumbled by -124bps to 0.7% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.7% in Q4 2025, 0.56% in Q3 2025, and 0.41% in Q2 2025.